Genetic variants as predictors of toxicity and response in patients with non‐small cell lung cancer undergoing first‐line platinum‐based chemotherapy: Design of the multicenter PGxLUNG study

INTRODUCTION: Platinum–based chemotherapy is currently the most frequently applied first‐line treatment for patients with advanced non‐small cell lung cancer (NSCLC) without targetable mutations or high PD‐L1 expression. Unfortunately, chemotherapy‐induced toxicity is prevalent and may affect patien...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Corine, Herder, Gerarda J.M., Deneer, Vera H.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705630/
https://www.ncbi.nlm.nih.gov/pubmed/33073546
http://dx.doi.org/10.1111/1759-7714.13683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705630/
https://www.ncbi.nlm.nih.gov/pubmed/33073546
http://dx.doi.org/10.1111/1759-7714.13683

Ejemplares similares